| 摘要: | 
			 
		     | 目的 研究5- 脂氧合酶(5-LOX)在恶唑酮诱导溃疡性结肠炎(UC)小鼠结肠黏膜中的表达情况,探讨其在UC 发病
机制中的作用及其与炎症程度的关系。方法 50只Balb/c小鼠分为正常对照组10 只和模型组40只。模型组用3%恶唑酮致敏2d,第5 天用0.5%恶唑酮灌肠。第8 天用颈椎脱臼法处死所有小鼠。实验期间观察小鼠疾病活动指数(DAI),处死小鼠后行结肠组织学病理评分(HPS)。RT-PCR 法检测结肠黏膜5-LOXmRNA 的表达,免疫组织化学方法检测结肠黏膜5-LOX 的蛋白表达情况。结果 模型组DAI 和HPS 均高于对照组,5-LOXmRNA和蛋白表达也明显高于对照组(均P<0.01),并随炎症程度加重,表达水平明显增高。结论 5-LOX 在UC 中表达水平明显升高,并参与了UC 的发生和发展,在一定程度上可反应疾病的活动度,并且可能作为药物治疗的潜在靶点。 | 
			
	         
				| 关键词:  溃疡性结肠炎  5-脂氧合酶  RT-PCR  免疫组织化学 | 
			 
                | DOI: | 
            
                | 分类号: | 
			 
             
                | 基金项目: | 
          |  | 
           
                | Expression of 5-lipoxygenase mRNA and protein in colon mucosa of mice with oxazolone-induced ulcerative colitis | 
           
			
                | ZHONG Wane, ZHANG Haifeng, ZHOU Guoxiong | 
           
		   
		   
                | Affiliated Hospital of Nantong University | 
		   
             
                | Abstract: | 
			
                | Objective To investigate the expression of 5-lipoxygenase (5-LOX ) mRNA in colon mucosa in mice with
oxazolone-induced ulcerative colitis (UC). Methods Fifty female Balb/c mice were divided into control group (n=10) and UC group (n=40). Mice in UC group received subcutaneous injection of 3% (w/v) oxazolone for 2d and subsequently received enema with 0.5%(w/v) oxazolone on d5 after sensitization. On d7 the mice were sacrificed for harvest of colon samples; disease activity index (DAI) and histopathological score (HPS) were also evaluated. The expression of 5-LOX mRNA and protein in colon mucosa were detected by RT-PCR and immunohistochemistry, respectively. Results The DAI and HPS were higher in UC group than those in control group. The expression of 5-LOX mRNA and protein were significantly increased in UC mice compared to controls(P<0.01), and the expression was positively correlated with the severity of colonic inflammation. Conclusion The expression of
5-LOX is up-regulated in colon mucosa of mice with oxazolone-induced ulcerative colitis, which indicates that 5-LOX may be involved in the development of UC and 5-LOX might be a potential pharmacological target for treatment of UC. | 
	       
                | Key words:  Ulcerative colitis  5-LOX  RT-PCR  Immunohistochemistry |